Pinaverium Bromide to Prevent Pain After Shock Wave Treatment
Part of Digestive system clinical trials.
This trial tests if a drug called pinaverium bromide can help prevent pancreatitis and reduce pain after a procedure that uses shock waves to break up large gallstones in the pancreas. It may be an option for people with chronic pancreatitis and stones that are at least 5 mm wide.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have chronic pancreatitis with painful stones in the pancreas that are at least 5 mm wide.
- The stones are mainly in the head or body of the pancreas.
- You are scheduled to have a procedure called P-ESWL (shock wave lithotripsy) to break up the stones.
- You have not had acute pancreatitis in the last 3 days.
- You are not allergic to pinaverium bromide.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of an NSAID (indomethacin) given rectally plus extra fluids through an IV can prevent pancreatitis after shock wave therapy for pancreatic stones. It may help reduce inflammation and protect your pancreas during treatment.
This study looks at whether brain patterns can predict how well endoscopic therapy works for chronic pancreatitis pain. If you have confirmed chronic pancreatitis with blockage in your pancreatic duct and frequent pain, you may be able to join.
This study tests a non-invasive pain treatment called scrambler therapy for people with chronic pancreatitis. It uses mild electrical signals on the skin to try to reduce long-term belly pain.
This trial tests whether using virtual reality (VR) can help reduce abdominal pain in people with chronic pancreatitis. If you have ongoing pain from chronic pancreatitis, you may be able to join and try VR as a non-drug pain management option.
This trial tests whether pirfenidone, an oral medication that may reduce scarring and inflammation, can help relieve pain in people with chronic pancreatitis. If you have ongoing pain or frequent flare-ups, this study could offer a new treatment option.
This Phase 1 study tests a new cell-based treatment to reduce pain caused by chronic pancreatitis. It’s designed mainly to check safety first, and it may help people with ongoing, opioid-stable pancreatic pain.
Hear when a new Chronic Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.